Showing results (501-510 of 843) with videos related to
Sort By:
Pageof 85
Journal of Virological Methods|August 25, 2017
Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120Jae-Sung Yu, Hua-Xin Liao, Jamie Pritchett, et al.Infection and Immunity|October 8, 2014
Gene deletions in Mycobacterium bovis BCG stimulate increased CD8+ T cell responsesMichael W Panas, Jaimie D Sixsmith, KeriAnn White, et al.Mucosal Immunology|January 10, 2013
HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-lifeN L Yates, A R Stacey, T L Nolen, et al.Biorxiv : the Preprint Server for Biology|July 9, 2020
A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodiesPriyamvada Acharya, Wilton Williams, Rory Henderson, et al.Cell Host & Microbe|March 11, 2021
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccinesXiaoying Shen, Haili Tang, Charlene McDanal, et al.Journal of Virology|September 16, 2011
Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformationS Munir Alam, Hua-Xin Liao, S Moses Dennison, et al.Journal of Virology|May 16, 2008
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigensMei-Yun Zhang, Bang K Vu, Anil Choudhary, et al.Journal of Virology|May 25, 2012
A short segment of the HIV-1 gp120 V1/V2 region is a major determinant of resistance to V1/V2 neutralizing antibodiesNicole A Doria-Rose, Ivelin Georgiev, Sijy O'Dell, et al.Science (New York, N.Y.)|June 25, 2021
Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicitySophie M-C Gobeil, Katarzyna Janowska, Shana McDowell, et al.Plos Pathogens|September 13, 2011
Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodiesBen-Jiang Ma, S Munir Alam, Eden P Go, et al.Pageof 85